Financial Reports
Related Searches:
Filter by:
April 21, 2008
Merck
1Q Revenues: $5.8 billion (+1%)
1Q Earnings: $3.3 billion (+94%)
Comments: Worldwide sales of Singulair were $1.1 billion (+10%); Cozaar and Hyzaar sales were $847 million (+6%); Fosamax and Fosamax Plus D sales were $470 million (-37…
Read More »
April 21, 2008
Lilly
1Q Revenues: $4.8 billion (+14%)
1Q Earnings: $1.1 billion (+109%)
Comments: Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve collectively grew 33% to $1.7 billion, and accounted for 35% of total…
Read More »
April 17, 2008
Pfizer
1Q Revenues: $11.8 billion (-5%)
1Q Earnings: $2.8 billion (-18%)
Comments: Pharmaceutical revenues in the quarter were $10.9 billion (-6%). Lipitor revenues were $3.1 billion (-7%), Celebrex revenues were $611 million (+2%), Lyrica r…
Read More »
April 17, 2008
Gilead Sciences
1Q Revenues: $1.3 billion (+22%)
1Q Earnings: $496.1 million (+22%)
Comments: The company achieved record product sales of $1.1 billion (+36%). HIV product sales were $964.7 million in the quarter (+37%). Truvada sales were…
Read More »
April 16, 2008
Abbott
1Q Revenues: $6.8 billion (+14%)
1Q Earnings: $937.9 million (+35%)
Comments: Growth in the quarter was driven by Humira, Niaspan and Kaletra. Humira sales were $878 million (+54%), Niaspan sales were $176 million (+24%), and Ka…
Read More »
April 15, 2008
J&J 1Q08
1Q Revenues: $16.2 billion (+8%)
1Q Earnings: $3.6 billion (+22%)
Comments: Pharmaceutical sales rose 3% to $6.4 billion, hurt by regulatory and safety issues for Procrit, as well as generic competition for Risperdal, Duragesic…
Read More »
April 11, 2008
Genentech
1Q Revenues: $3.1 billion (+8%)
1Q Earnings: $790 million (+12%)
Comments: Rituxan sales were $605 million (+13%), Avastin sales were $600 million (+13%), and Herceptin sales were $339 million (+9%). 1Q08 Avastin U.S. sales includ…
Read More »
March 7, 2008
Patheon 1Q08
1Q Revenues: $164 million (+11%)
1Q Loss: $15 million (net loss of $2 million in 1Q07)
Comments: Revenues from European operations grew 35% to $20 million, but weakness of the U.S. dollar added $6.9 million to that result. On a…
Read More »
February 28, 2008
Hospira
4Q Revenues: $946.1 million (+34%)
4Q Earnings: $76.1 million (+61%)
FY Revenues: $3.4 billion (+28%)
FY Earnings: $136.8 million (-43%)
Comments: Sales in the quarter and FY excluding Mayne Pharma sales grew 8% and 4%,…
Read More »
February 13, 2008
Genzyme
4Q Revenues: $1.0 billion (+21%)
4Q Earnings: $78.9 million (loss of $268.2 million 4Q06)
FY Revenues: $3.8 billion (+20%)
FY Earnings: $480.2 million (loss of $16.8 million FY06)
Comments: Revenue growth was driven by strong sales of it…
Read More »
February 12, 2008
Schering-Plough
4Q Revenues: $3.7 billion (+41%)
4Q Loss: $3.3 billion (earnings were $204 million in 4Q06)
FY Revenues: $12.7 billion (+20%)
FY Loss: $1.5 billion (earnings were $1.1 billion FY06)
Comments: Global pharmaceutical…
Read More »
February 12, 2008
Catalent Pharma Solutions
2Q Revenues: $464 million (+11%)
2Q Loss: $30.2 million (earnings were $18.5 million 4Q06)
YTD Revenues: $902 million (+11%)
YTD Loss: $41.5 million (earnings were $19.6 million YTD06)
Comments: Revenue growt…
Read More »
February 11, 2008
AMRI
4Q Revenues: $47.2 million (+1%)
4Q Loss: $844,000 (loss of $764,000 in 4Q2006)
FY Revenues: $192.5 million (+7%)
FY Earnings: $8.9 million (earnings were $2.2 million FY2006)
Comments: Total contract and milestone revenue for th…
Read More »
February 8, 2008
GlaxoSmithKline
4Q Revenues: $12.1 billion (+5%)
4Q Earnings: $2.2 billion (-6%)
FY Revenues: $45.4 billion (+6%)
FY Earnings: $10.6 billion (+4%)
Comments: Advair sales were $7.0 billion for the year (+15%) and $1.9 billion in…
Read More »
February 7, 2008
Millennium
4Q Revenues: $181.2 million (+30%)
4Q Earnings: $41.0 million (earnings were $8.3 million in 4Q2006)
FY Revenues: $527.5 million (+8%)
FY Earnings: $14.9 million (loss of $44.0 million FY2006)
Comments: U.S. sales of…
Read More »
